News | News By Subject | News by Disease News By Date | Search News

Anemia, sickle cell News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Tiny Bicycle Therapeutics Wrangles a $424 Million R&D Pact With Biogen (BIIB) Spinoff Bioverativ (BIVV)     9/7/2017
Global Blood Therapeutics (GBT) Stock Surges on Promising Sickle Cell Drug Results     6/10/2016
bluebird bio (BLUE) Gets Banged Up on Report of Gene Therapy Patient Needing Blood Transfusions     10/21/2015
Novartis AG (NVS) Takes Another 2.5% Stake in Gamida Cell     10/12/2015
bluebird bio (BLUE) Surges as Pioneering Sickle Cell Gene Therapy Working for 13-Year-Old French Boy     6/18/2015
Stock Soars as bluebird bio (BLUE) Gives Sneak Peek at Promising Sickle Cell Data     5/26/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
J.P. Morgan: bluebird bio (BLUE) Soars On CEO's Sickle Cell Data     1/16/2015
bluebird bio (BLUE)’s New Blood Treatment Could Benefit Sickle Cell, Says Analyst     12/9/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
LentiGlobin Looks Promising On Sickle Cell For bluebird bio (BLUE), Says Analyst     11/19/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Cellerant Therapeutics, Inc. Raises $16 Million To Advance Stem Cell-Based Therapies For Life-Threatening Diseases; Series B proceeds To Fund Cancer, Sickle Cell And Autoimmune Programs     5/11/2005
National Institutes of Health (NIH) Issues Alert; Federal Health Agency Halts Sickle Cell Study Because Subjects Suffer Strokes     12/6/2004
Icagen, Inc. Receives Milestone Payment From McNeil Consumer & Specialty Pharmaceuticals (JNJ)     9/2/2004

News from Around the Web
Why 2017 Will be a Data-Rich and Not Revenue-Focused Year for bluebird bio (BLUE)     2/24/2017
Stanford University Researchers Use CRISPR to Repair Gene That Cause Sickle Cell, Human Trials Planned     11/8/2016
An Easy Test for Sickle Cell Disease, University of Connecticut Study     11/5/2015
Stem Cell Transplant Stops Sickle Cell In Potential Cure, National Institutes of Health (NIH) Reveals     7/2/2014
Malaria May Be Eliminated From a Quarter of Nations in 10 Years, Roll Back Malaria Partnership Reveals     10/18/2011
Fetal Hemoglobin Production Reverses Sickle Cell Anemia, Dana-Farber Cancer Institute Study     10/14/2011
Common Drug Helps Babies with Sickle Cell Disease, St. Jude Children's Research Hospital Study Finds     5/13/2011
American Society of Hematology: Compound Cuts Death Risk for Sickle Cell Kids     12/6/2010
Inhaling Nitric Oxide Eases Pain Crises in Sickle Cell Patients, Medical College of Georgia Researchers Find     10/20/2010
National Heart, Lung, and Blood Institute Stops Study of Treatment for Pulmonary Hypertension in Patients with Sickle Cell Disease Due to Safety Concerns     7/28/2009
Gene May Open Door For New Sickle Cell Therapies, Harvard Medical School Study     12/5/2008
Researchers At Johns Hopkins University Develop Stem Line With Sickle Cell Mutation     5/30/2008
Scientists Cure Mice With Sickle Cell     12/7/2007
Anticancer Drugs Might be of Benefit to Sickle-Cell Patients     12/7/2007
Blood Test Predicts Sickle Cell Disease Complication, Identifies Patients At High Risk Of Death     7/19/2006

Press Releases
Global Blood Therapeutics (GBT) To Convene Sickle Cell Disease Influencers At Annual Sickle Cell Disease (SCD) Therapeutics Conference     9/6/2017
Global Blood Therapeutics (GBT) Receives Rare Pediatric Disease Designation From FDA For GBT440 For Treatment Of Sickle Cell Disease (SCD)     9/5/2017
Sancilio Pharmaceuticals Company, Inc. Announces Completion Of Enrollment In The SCOT Trial In Pediatric Patients With Sickle Cell Disease Using Altemia Capsules     7/27/2017
Global Blood Therapeutics (GBT) Expands Ongoing Phase IIa HOPE-KIDS 1 Study Into Younger Pediatric Population     7/10/2017
Apellis Pharma Release: Positive Data From APL-2 Studies Show Rapid And Durable Improvements In LDH And Hemoglobin Levels     6/29/2017
Global Blood Therapeutics (GBT) Receives EMA PRIME Designation For GBT440 For The Treatment Of Sickle Cell Disease (SCD)     6/28/2017
bluebird bio (BLUE) Presents New Data From HGB-205 Study Of LentiGlobin Drug Product In Patients With Transfusion-Dependent ?-Thalassemia (TDT) And Severe Sickle Cell Disease (SCD) At European Hematology Association Annual Meeting     6/23/2017
Global Blood Therapeutics (GBT) Announces New Data Supporting Ongoing Clinical Development Of GBT440 In Adolescents With Sickle Cell Disease     6/23/2017
Experimental Biology And Medicine Release: Lipoprotein Abnormalities Contribute To Sickle Cell Disease Pathology     6/23/2017
European Hematology Association: Treating Sickle Cell Disease And Beta-Thalassemia With CRISPR/Cas9 Gene Editing     6/23/2017
Little-Known Emmaus Life Sciences Wins FDA Panel Backing for Sickle Cell Disease Med     5/25/2017
Imara Receives Rare Pediatric Disease Designation From FDA For Lead Product Candidate IMR-687 For Sickle Cell Disease     5/15/2017
Emmaus Life Sciences Announces FDA Advisory Committee Meeting For Endari For Sickle Cell Disease     4/18/2017
AllCells Selected By Children’s Hospital Oakland Research Institute (CHORI) To Perform Blood Processing Of SCD Patients Under CIRM Translational Award Program     3/23/2017
bluebird bio (BLUE) Announces Publication Of Case Study On First Patient With Severe Sickle Cell Disease Treated With Gene Therapy In The New England Journal of Medicine     3/2/2017